OTULIN and Stroke: Adding HOIP to the clinical model increased the AUC from 0.846 to 0.907 and further improved model calibration and clinical net benefit.<h4>Conclusion</h4>Peripheral blood HOIP and OTULIN may serve as candidate biomarkers associated with stroke severity in AIS, while HOIP may provide additional prognostic information for functional outcome.